Ondansetron Injection USP

SteriMax is pleased to announce the launch of Ondansetron 8 mg / 4 mL (2 mg / mL). To learn more visit the Ondansetron product page.

Ondansetron Injection USP

SteriMax is pleased to announce the launch of Ondansetron 4 mg/ 2 mL (2 mg / mL). To learn more visit the Ondansetron product page.

Furosemide Injection USP

Furosemide Injection USP SteriMax is pleased to announce the launch of Furosemide for Injection. To learn more visit the Furosemide product page.

Bupivacaine Hydrochloride in Dextrose Injection USP 0.75%

Bupivacaine Injection   SteriMax is pleased to announce the launch of Bupivacaine Hydrochlorhide in Dextrose Injection USP. To learn more visit the Bupivacaine product page.

Busulfan for Injection

SteriMax is pleased to announce the launch of Busulfan. To learn more visit the Busulfan product page.

SteriMax New Product Acquisition

SteriMax is pleased to announce the acquisition of the following products from Valeant Canada effective December 1st, 2017.

Furosemide for Injection

SteriMax is pleased to announce the launch of Furosemide for Injection. To learn more visit the Furosemide product page.